Who Paid My Doc
Sarah Hughes
Gynecologic Oncology Worcester, MA Medical Doctor
NPI 1669663761 CMS profile 1065459
119 Belmont St, Worcester, MA 01605
General payments
$45
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Sarah Hughes of Worcester, MA is reported in the CMS Open Payments database as having received $45 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 4th percentile of Gynecologic Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $45 | 1 |
Beside peers
- Sarah Hughes
- Gynecologic Oncology median
- Middle half of Gynecologic Oncology
- National median
In program year 2025, general payments to Sarah Hughes were reported at $45. Among 1,179 Gynecologic Oncology profiles paid that year, the median was $305 and the middle half received between $111 and $1,499.
Show as a table
| Year | Sarah Hughes | Gynecologic Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $287 | $113–$1,548 | $163 |
| 2020 | $0 | $223 | $59–$2,164 | $114 |
| 2021 | $0 | $193 | $68–$1,139 | $132 |
| 2022 | $0 | $252 | $90–$1,151 | $149 |
| 2023 | $0 | $281 | $102–$1,419 | $160 |
| 2024 | $0 | $308 | $108–$1,502 | $164 |
| 2025 | $45 | $305 | $111–$1,499 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
349
Drug cost
$561,478
Branded share of claims
29.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Lynparza Olaparib | Brand | 33 | $521,839 | |
| Eliquis Apixaban | Brand | 43 | $33,817 | |
| Estradiol | Generic | 19 | $1,658 | |
| Prochlorperazine Maleate | Generic | 45 | $1,125 | |
| Letrozole | Generic | 38 | $837 | |
| Clobetasol Propionate | Generic | 19 | $698 | |
| Dexamethasone | Generic | 57 | $628 | |
| Ondansetron Hcl | Generic | 36 | $336 | |
| Omeprazole | Generic | 17 | $215 | |
| Famotidine | Generic | 16 | $171 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 860 Part D prescribers listed as Gynecological Oncology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 34 billing codesPaid by Medicare
$42,278
Medicare patients
152
Services billed
369
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 72% | |
| Cancer | 49% | |
| Arthritis | 41% | |
| Diabetes | 26% | |
| Depression | 24% | |
| Chronic kidney disease | 23% | |
| Osteoporosis | 20% | |
| Ischemic heart disease | 14% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Gynecologic Oncology in Massachusetts
Amy Bregar
Gynecologic Oncology · Boston, MA
Whitfield Growdon
Gynecologic Oncology · Boston, MA
Alexander Melamed
Gynecologic Oncology · Boston, MA
Tashanna Myers
Gynecologic Oncology · Springfield, MA
Sarah Paraghamian
Gynecologic Oncology · Boston, MA
Michael Muto
Gynecologic Oncology · Boston, MA
Related records
Gynecologic Oncology in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Gynecologic Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.